Screener
Eligibility screening
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
16 US sites in CA, CO, FL, LA +9
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.